XML 68 R51.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($)
$ in Millions
 3 Months Ended
Apr. 01, 2018
Apr. 02, 2017
Sales by segment of business    
Sales $ 20,009 $ 17,766
Percent Change (as a percent) 12.60%  
U.S.    
Sales by segment of business    
Sales $ 9,951 9,378
Percent Change (as a percent) 6.10%  
International    
Sales by segment of business    
Sales $ 10,058 8,388
Percent Change (as a percent) 19.90%  
CONSUMER    
Sales by segment of business    
Sales $ 3,398 3,228
Percent Change (as a percent) 5.30%  
CONSUMER | U.S.    
Sales by segment of business    
Sales $ 1,436 1,414
Percent Change (as a percent) 1.60%  
CONSUMER | International    
Sales by segment of business    
Sales $ 1,962 1,814
Percent Change (as a percent) 8.20%  
CONSUMER | Baby Care    
Sales by segment of business    
Sales $ 457 455
Percent Change (as a percent) 0.40%  
CONSUMER | Baby Care | U.S.    
Sales by segment of business    
Sales $ 97 113
Percent Change (as a percent) (14.20%)  
CONSUMER | Baby Care | International    
Sales by segment of business    
Sales $ 360 342
Percent Change (as a percent) 5.30%  
CONSUMER | Beauty    
Sales by segment of business    
Sales $ 1,084 981
Percent Change (as a percent) 10.50%  
CONSUMER | Beauty | U.S.    
Sales by segment of business    
Sales $ 611 567
Percent Change (as a percent) 7.80%  
CONSUMER | Beauty | International    
Sales by segment of business    
Sales $ 473 414
Percent Change (as a percent) 14.30%  
CONSUMER | Oral Care    
Sales by segment of business    
Sales $ 379 362
Percent Change (as a percent) 4.70%  
CONSUMER | Oral Care | U.S.    
Sales by segment of business    
Sales $ 157 156
Percent Change (as a percent) 0.60%  
CONSUMER | Oral Care | International    
Sales by segment of business    
Sales $ 222 206
Percent Change (as a percent) 7.80%  
CONSUMER | OTC    
Sales by segment of business    
Sales $ 1,072 1,013
Percent Change (as a percent) 5.80%  
CONSUMER | OTC | U.S.    
Sales by segment of business    
Sales $ 465 477
Percent Change (as a percent) (2.50%)  
CONSUMER | OTC | International    
Sales by segment of business    
Sales $ 607 536
Percent Change (as a percent) 13.20%  
CONSUMER | Women's Health    
Sales by segment of business    
Sales $ 243 242
Percent Change (as a percent) 0.40%  
CONSUMER | Women's Health | U.S.    
Sales by segment of business    
Sales $ 3 3
Percent Change (as a percent) 0.00%  
CONSUMER | Women's Health | International    
Sales by segment of business    
Sales $ 240 239
Percent Change (as a percent) 0.40%  
CONSUMER | Wound Care/Other    
Sales by segment of business    
Sales $ 163 175
Percent Change (as a percent) (6.90%)  
CONSUMER | Wound Care/Other | U.S.    
Sales by segment of business    
Sales $ 103 98
Percent Change (as a percent) 5.10%  
CONSUMER | Wound Care/Other | International    
Sales by segment of business    
Sales $ 60 77
Percent Change (as a percent) (22.10%)  
PHARMACEUTICAL    
Sales by segment of business    
Sales $ 9,844 8,245
Percent Change (as a percent) 19.40%  
PHARMACEUTICAL | U.S.    
Sales by segment of business    
Sales $ 5,354 4,872
Percent Change (as a percent) 9.90%  
PHARMACEUTICAL | International    
Sales by segment of business    
Sales $ 4,490 3,373
Percent Change (as a percent) 33.10%  
PHARMACEUTICAL | Immunology    
Sales by segment of business    
Sales $ 3,042 2,930
Percent Change (as a percent) 3.80%  
PHARMACEUTICAL | Immunology | U.S.    
Sales by segment of business    
Sales $ 2,000 2,123
Percent Change (as a percent) (5.80%)  
PHARMACEUTICAL | Immunology | International    
Sales by segment of business    
Sales $ 1,042 807
Percent Change (as a percent) 29.10%  
PHARMACEUTICAL | Immunology | REMICADE®    
Sales by segment of business    
Sales $ 1,389 1,672
Percent Change (as a percent) (16.90%)  
PHARMACEUTICAL | Immunology | REMICADE® | U.S.    
Sales by segment of business    
Sales $ 916 1,182
Percent Change (as a percent) (22.50%)  
PHARMACEUTICAL | Immunology | REMICADE® | U.S. Exports    
Sales by segment of business    
Sales $ 142 165
Percent Change (as a percent) (13.90%)  
PHARMACEUTICAL | Immunology | REMICADE® | International    
Sales by segment of business    
Sales $ 331 325
Percent Change (as a percent) 1.80%  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA®    
Sales by segment of business    
Sales $ 518 428
Percent Change (as a percent) 21.00%  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | U.S.    
Sales by segment of business    
Sales $ 224 229
Percent Change (as a percent) (2.20%)  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | International    
Sales by segment of business    
Sales $ 294 199
Percent Change (as a percent) 47.70%  
PHARMACEUTICAL | Immunology | STELARA®    
Sales by segment of business    
Sales $ 1,061 823
Percent Change (as a percent) 28.90%  
PHARMACEUTICAL | Immunology | STELARA® | U.S.    
Sales by segment of business    
Sales $ 652 547
Percent Change (as a percent) 19.20%  
PHARMACEUTICAL | Immunology | STELARA® | International    
Sales by segment of business    
Sales $ 409 276
Percent Change (as a percent) 48.20%  
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY    
Sales by segment of business    
Sales $ 74 7
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | U.S.    
Sales by segment of business    
Sales 66 0
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | International    
Sales by segment of business    
Sales $ 8 7
Percent Change (as a percent) 14.30%  
PHARMACEUTICAL | Infectious Diseases    
Sales by segment of business    
Sales $ 830 749
Percent Change (as a percent) 10.80%  
PHARMACEUTICAL | Infectious Diseases | U.S.    
Sales by segment of business    
Sales $ 333 326
Percent Change (as a percent) 2.10%  
PHARMACEUTICAL | Infectious Diseases | International    
Sales by segment of business    
Sales $ 497 423
Percent Change (as a percent) 17.50%  
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine    
Sales by segment of business    
Sales $ 210 149
Percent Change (as a percent) 40.90%  
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | U.S.    
Sales by segment of business    
Sales $ 14 12
Percent Change (as a percent) 16.70%  
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | International    
Sales by segment of business    
Sales $ 196 137
Percent Change (as a percent) 43.10%  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA®    
Sales by segment of business    
Sales $ 478 430
Percent Change (as a percent) 11.20%  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | U.S.    
Sales by segment of business    
Sales $ 273 259
Percent Change (as a percent) 5.40%  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | International    
Sales by segment of business    
Sales $ 205 171
Percent Change (as a percent) 19.90%  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES    
Sales by segment of business    
Sales $ 142 170
Percent Change (as a percent) (16.50%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S.    
Sales by segment of business    
Sales $ 46 55
Percent Change (as a percent) (16.40%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | International    
Sales by segment of business    
Sales $ 96 115
Percent Change (as a percent) (16.50%)  
PHARMACEUTICAL | Neuroscience    
Sales by segment of business    
Sales $ 1,559 1,497
Percent Change (as a percent) 4.10%  
PHARMACEUTICAL | Neuroscience | U.S.    
Sales by segment of business    
Sales $ 624 664
Percent Change (as a percent) (6.00%)  
PHARMACEUTICAL | Neuroscience | International    
Sales by segment of business    
Sales $ 935 833
Percent Change (as a percent) 12.20%  
PHARMACEUTICAL | Neuroscience | CONCERTA® / Methylphenidate    
Sales by segment of business    
Sales $ 173 209
Percent Change (as a percent) (17.20%)  
PHARMACEUTICAL | Neuroscience | CONCERTA® / Methylphenidate | U.S.    
Sales by segment of business    
Sales $ 66 108
Percent Change (as a percent) (38.90%)  
PHARMACEUTICAL | Neuroscience | CONCERTA® / Methylphenidate | International    
Sales by segment of business    
Sales $ 107 101
Percent Change (as a percent) 5.90%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / TRINZA® / TREVICTA®    
Sales by segment of business    
Sales $ 696 604
Percent Change (as a percent) 15.20%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / TRINZA® / TREVICTA® | U.S.    
Sales by segment of business    
Sales $ 400 372
Percent Change (as a percent) 7.50%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / TRINZA® / TREVICTA® | International    
Sales by segment of business    
Sales $ 296 232
Percent Change (as a percent) 27.60%  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA®    
Sales by segment of business    
Sales $ 196 207
Percent Change (as a percent) (5.30%)  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | U.S.    
Sales by segment of business    
Sales $ 82 95
Percent Change (as a percent) (13.70%)  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | International    
Sales by segment of business    
Sales $ 114 112
Percent Change (as a percent) 1.80%  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE    
Sales by segment of business    
Sales $ 494 477
Percent Change (as a percent) 3.60%  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | U.S.    
Sales by segment of business    
Sales $ 76 89
Percent Change (as a percent) (14.60%)  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | International    
Sales by segment of business    
Sales $ 418 388
Percent Change (as a percent) 7.70%  
PHARMACEUTICAL | Oncology    
Sales by segment of business    
Sales $ 2,311 1,594
Percent Change (as a percent) 45.00%  
PHARMACEUTICAL | Oncology | U.S.    
Sales by segment of business    
Sales $ 933 664
Percent Change (as a percent) 40.50%  
PHARMACEUTICAL | Oncology | International    
Sales by segment of business    
Sales $ 1,378 930
Percent Change (as a percent) 48.20%  
PHARMACEUTICAL | Oncology | DARZALEX®    
Sales by segment of business    
Sales $ 432 255
Percent Change (as a percent) 69.40%  
PHARMACEUTICAL | Oncology | DARZALEX® | U.S.    
Sales by segment of business    
Sales $ 264 201
Percent Change (as a percent) 31.30%  
PHARMACEUTICAL | Oncology | DARZALEX® | International    
Sales by segment of business    
Sales $ 168 54
PHARMACEUTICAL | Oncology | IMBRUVICA®    
Sales by segment of business    
Sales $ 587 409
Percent Change (as a percent) 43.50%  
PHARMACEUTICAL | Oncology | IMBRUVICA® | U.S.    
Sales by segment of business    
Sales $ 227 190
Percent Change (as a percent) 19.50%  
PHARMACEUTICAL | Oncology | IMBRUVICA® | International    
Sales by segment of business    
Sales $ 360 219
Percent Change (as a percent) 64.40%  
PHARMACEUTICAL | Oncology | VELCADE®    
Sales by segment of business    
Sales $ 313 280
Percent Change (as a percent) 11.80%  
PHARMACEUTICAL | Oncology | VELCADE® | U.S.    
Sales by segment of business    
Sales $ 0 0
Percent Change (as a percent) 0.00%  
PHARMACEUTICAL | Oncology | VELCADE® | International    
Sales by segment of business    
Sales $ 313 280
Percent Change (as a percent) 11.80%  
PHARMACEUTICAL | Oncology | ZYTIGA®    
Sales by segment of business    
Sales $ 845 523
Percent Change (as a percent) 61.60%  
PHARMACEUTICAL | Oncology | ZYTIGA® | U.S.    
Sales by segment of business    
Sales $ 407 233
Percent Change (as a percent) 74.70%  
PHARMACEUTICAL | Oncology | ZYTIGA® | International    
Sales by segment of business    
Sales $ 438 290
Percent Change (as a percent) 51.00%  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY    
Sales by segment of business    
Sales $ 134 127
Percent Change (as a percent) 5.50%  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | U.S.    
Sales by segment of business    
Sales $ 35 40
Percent Change (as a percent) (12.50%)  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | International    
Sales by segment of business    
Sales $ 99 87
Percent Change (as a percent) 13.80%  
PHARMACEUTICAL | Pulmonary Hypertension    
Sales by segment of business    
Sales $ 585 0
PHARMACEUTICAL | Pulmonary Hypertension | U.S.    
Sales by segment of business    
Sales 361 0
PHARMACEUTICAL | Pulmonary Hypertension | International    
Sales by segment of business    
Sales 224 0
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT®    
Sales by segment of business    
Sales 271 0
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | U.S.    
Sales by segment of business    
Sales 149 0
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | International    
Sales by segment of business    
Sales 122 0
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER®    
Sales by segment of business    
Sales 140 0
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER® | U.S.    
Sales by segment of business    
Sales 68 0
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER® | International    
Sales by segment of business    
Sales 72 0
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI®    
Sales by segment of business    
Sales 140 0
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | U.S.    
Sales by segment of business    
Sales 124 0
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | International    
Sales by segment of business    
Sales 16 0
PHARMACEUTICAL | Pulmonary Hypertension | OTHER    
Sales by segment of business    
Sales 34 0
PHARMACEUTICAL | Pulmonary Hypertension | OTHER | U.S.    
Sales by segment of business    
Sales 20 0
PHARMACEUTICAL | Pulmonary Hypertension | OTHER | International    
Sales by segment of business    
Sales 14 0
PHARMACEUTICAL | Cardiovascular / Metabolism / Other    
Sales by segment of business    
Sales $ 1,517 1,475
Percent Change (as a percent) 2.80%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | U.S.    
Sales by segment of business    
Sales $ 1,103 1,095
Percent Change (as a percent) 0.70%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | International    
Sales by segment of business    
Sales $ 414 380
Percent Change (as a percent) 8.90%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER    
Sales by segment of business    
Sales $ 415 431
Percent Change (as a percent) (3.70%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER | U.S.    
Sales by segment of business    
Sales $ 132 166
Percent Change (as a percent) (20.50%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER | International    
Sales by segment of business    
Sales $ 283 265
Percent Change (as a percent) 6.80%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO®    
Sales by segment of business    
Sales $ 578 513
Percent Change (as a percent) 12.70%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | U.S.    
Sales by segment of business    
Sales $ 578 513
Percent Change (as a percent) 12.70%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | International    
Sales by segment of business    
Sales $ 0 0
Percent Change (as a percent) 0.00%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET®    
Sales by segment of business    
Sales $ 248 284
Percent Change (as a percent) (12.70%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | U.S.    
Sales by segment of business    
Sales $ 204 247
Percent Change (as a percent) (17.40%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | International    
Sales by segment of business    
Sales $ 44 37
Percent Change (as a percent) 18.90%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX®    
Sales by segment of business    
Sales $ 276 247
Percent Change (as a percent) 11.70%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | U.S.    
Sales by segment of business    
Sales $ 189 169
Percent Change (as a percent) 11.80%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | International    
Sales by segment of business    
Sales $ 87 78
Percent Change (as a percent) 11.50%  
MEDICAL DEVICES    
Sales by segment of business    
Sales $ 6,767 6,293
Percent Change (as a percent) 7.50%  
MEDICAL DEVICES | U.S.    
Sales by segment of business    
Sales $ 3,161 3,092
Percent Change (as a percent) 2.20%  
MEDICAL DEVICES | International    
Sales by segment of business    
Sales $ 3,606 3,201
Percent Change (as a percent) 12.70%  
MEDICAL DEVICES | Diabetes Care    
Sales by segment of business    
Sales $ 339 399
Percent Change (as a percent) (15.00%)  
MEDICAL DEVICES | Diabetes Care | U.S.    
Sales by segment of business    
Sales $ 117 154
Percent Change (as a percent) (24.00%)  
MEDICAL DEVICES | Diabetes Care | International    
Sales by segment of business    
Sales $ 222 245
Percent Change (as a percent) (9.40%)  
MEDICAL DEVICES | Diagnostics    
Sales by segment of business    
Sales $ 0 1
MEDICAL DEVICES | Diagnostics | U.S.    
Sales by segment of business    
Sales 0 0
MEDICAL DEVICES | Diagnostics | International    
Sales by segment of business    
Sales 0 1
MEDICAL DEVICES | Interventional Solutions    
Sales by segment of business    
Sales $ 640 549
Percent Change (as a percent) 16.60%  
MEDICAL DEVICES | Interventional Solutions | U.S.    
Sales by segment of business    
Sales $ 304 279
Percent Change (as a percent) 9.00%  
MEDICAL DEVICES | Interventional Solutions | International    
Sales by segment of business    
Sales $ 336 270
Percent Change (as a percent) 24.40%  
MEDICAL DEVICES | Orthopaedics    
Sales by segment of business    
Sales $ 2,250 2,275
Percent Change (as a percent) (1.10%)  
MEDICAL DEVICES | Orthopaedics | U.S.    
Sales by segment of business    
Sales $ 1,307 1,359
Percent Change (as a percent) (3.80%)  
MEDICAL DEVICES | Orthopaedics | International    
Sales by segment of business    
Sales $ 943 916
Percent Change (as a percent) 2.90%  
MEDICAL DEVICES | Orthopaedics | HIPS    
Sales by segment of business    
Sales $ 363 352
Percent Change (as a percent) 3.10%  
MEDICAL DEVICES | Orthopaedics | HIPS | U.S.    
Sales by segment of business    
Sales $ 209 209
Percent Change (as a percent) 0.00%  
MEDICAL DEVICES | Orthopaedics | HIPS | International    
Sales by segment of business    
Sales $ 154 143
Percent Change (as a percent) 7.70%  
MEDICAL DEVICES | Orthopaedics | KNEES    
Sales by segment of business    
Sales $ 387 398
Percent Change (as a percent) (2.80%)  
MEDICAL DEVICES | Orthopaedics | KNEES | U.S.    
Sales by segment of business    
Sales $ 228 246
Percent Change (as a percent) (7.30%)  
MEDICAL DEVICES | Orthopaedics | KNEES | International    
Sales by segment of business    
Sales $ 159 152
Percent Change (as a percent) 4.60%  
MEDICAL DEVICES | Orthopaedics | TRAUMA    
Sales by segment of business    
Sales $ 696 642
Percent Change (as a percent) 8.40%  
MEDICAL DEVICES | Orthopaedics | TRAUMA | U.S.    
Sales by segment of business    
Sales $ 407 391
Percent Change (as a percent) 4.10%  
MEDICAL DEVICES | Orthopaedics | TRAUMA | International    
Sales by segment of business    
Sales $ 289 251
Percent Change (as a percent) 15.10%  
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER    
Sales by segment of business    
Sales $ 804 883
Percent Change (as a percent) (8.90%)  
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER | U.S.    
Sales by segment of business    
Sales $ 463 513
Percent Change (as a percent) (9.70%)  
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER | International    
Sales by segment of business    
Sales $ 341 370
Percent Change (as a percent) (7.80%)  
MEDICAL DEVICES | Surgery    
Sales by segment of business    
Sales $ 2,423 2,271
Percent Change (as a percent) 6.70%  
MEDICAL DEVICES | Surgery | U.S.    
Sales by segment of business    
Sales $ 993 995
Percent Change (as a percent) (0.20%)  
MEDICAL DEVICES | Surgery | International    
Sales by segment of business    
Sales $ 1,430 1,276
Percent Change (as a percent) 12.10%  
MEDICAL DEVICES | Surgery | ADVANCED    
Sales by segment of business    
Sales $ 966 877
Percent Change (as a percent) 10.10%  
MEDICAL DEVICES | Surgery | ADVANCED | U.S.    
Sales by segment of business    
Sales $ 393 392
Percent Change (as a percent) 0.30%  
MEDICAL DEVICES | Surgery | ADVANCED | International    
Sales by segment of business    
Sales $ 573 485
Percent Change (as a percent) 18.10%  
MEDICAL DEVICES | Surgery | GENERAL    
Sales by segment of business    
Sales $ 1,127 1,074
Percent Change (as a percent) 4.90%  
MEDICAL DEVICES | Surgery | GENERAL | U.S.    
Sales by segment of business    
Sales $ 423 423
Percent Change (as a percent) 0.00%  
MEDICAL DEVICES | Surgery | GENERAL | International    
Sales by segment of business    
Sales $ 704 651
Percent Change (as a percent) 8.10%  
MEDICAL DEVICES | Surgery | SPECIALTY    
Sales by segment of business    
Sales $ 330 320
Percent Change (as a percent) 3.10%  
MEDICAL DEVICES | Surgery | SPECIALTY | U.S.    
Sales by segment of business    
Sales $ 177 180
Percent Change (as a percent) (1.70%)  
MEDICAL DEVICES | Surgery | SPECIALTY | International    
Sales by segment of business    
Sales $ 153 140
Percent Change (as a percent) 9.30%  
MEDICAL DEVICES | Vision Care    
Sales by segment of business    
Sales $ 1,115 798
Percent Change (as a percent) 39.70%  
MEDICAL DEVICES | Vision Care | U.S.    
Sales by segment of business    
Sales $ 440 305
Percent Change (as a percent) 44.30%  
MEDICAL DEVICES | Vision Care | International    
Sales by segment of business    
Sales $ 675 493
Percent Change (as a percent) 36.90%  
MEDICAL DEVICES | Vision Care | CONTACT LENSES / OTHER    
Sales by segment of business    
Sales $ 807 683
Percent Change (as a percent) 18.20%  
MEDICAL DEVICES | Vision Care | CONTACT LENSES / OTHER | U.S.    
Sales by segment of business    
Sales $ 309 256
Percent Change (as a percent) 20.70%  
MEDICAL DEVICES | Vision Care | CONTACT LENSES / OTHER | International    
Sales by segment of business    
Sales $ 498 427
Percent Change (as a percent) 16.60%  
MEDICAL DEVICES | Vision Care | SURGICAL    
Sales by segment of business    
Sales $ 308 115
MEDICAL DEVICES | Vision Care | SURGICAL | U.S.    
Sales by segment of business    
Sales 131 49
MEDICAL DEVICES | Vision Care | SURGICAL | International    
Sales by segment of business    
Sales $ 177 $ 66